Just to name 2: max cooper / jacques miller for B and T cells (yes, they havent won the Nobel), druker/lydon/sawyers for imatinib (one of the few if not the only true magic bullet for a cancer so far) as obesity rates fall, chronic disease incidence will fall as well, and aging rates will decelerate: Excited for the Nobel announcements
What makes BPC-157 distinctive among research peptides is a combination of three properties rarely found together: it has no sequence homology to any other known peptide, it is completely stable in human gastric acid for at least 24 hours (unlike most growth factors and peptide analogues, which are rapidly degraded), and it remains active across an exceptionally broad effective dose range from nanogram to microgram per kilogram bodyweight in pre-clinical models without any known toxic dose having been established in animal studies to date
Haven't received our newsletter
GHRP-6 has proved to prevent and attenuate cardiac cell death and left ventricular failure in multiple experimental scenarios
Related Stories Training helps pediatricians independently treat child anxiety and depression New review shows why antidepressants often fail in Alzheimers and Parkinsons depression Compulsive smartphone use linked to higher depression risk in older adults Secondary outcomes were SUD subtypes (alcohol dependence and cannabis use disorder), mental health disorder subtypes (BD I, BD II, and postpartum depression), and the four mental well-being dimensions (positive affect, depressive symptoms, life satisfaction, and neuroticism)
Ruling Out Other Conditions Diagnosing gastroparesis also means checking for other conditions that might cause similar symptoms